©2022 Stanford Medicine
Selegiline Patch for Treatment of Nicotine Dependence
Not Recruiting
Trial ID: NCT01330030
Purpose
Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of
this study is examine whether selegiline, given in the form of a skin patch, is effective in
stopping smoking.
Official Title
Selegiline Patch for Treatment of Nicotine Dependence
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
- Smokes greater than 20 cigarettes per day
Exclusion Criteria:
- History of Parkinson's disease, high blood pressure, or severe liver or kidney disease
- Current substance abuse
- Mental illness
- Skin conditions that could interfere with patch use
- Using antidepressant medications (e.g., levodopa/carbidopa, methyldopa, or any MAO
inhibitor)
- Pregnant or breastfeeding
Intervention(s):
other: matching placebo
drug: Selegiline
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Joel Killen
6507259443